Structural localization of disease-associated sequence variations in the NACHT and LRR domains of PYPAF1 and NOD2.
about
Blau syndrome polymorphisms in NOD2 identify nucleotide hydrolysis and helical domain 1 as signalling regulatorsCryopyrin-induced interleukin 1beta secretion in monocytic cells: enhanced activity of disease-associated mutants and requirement for ASCBiochemical and structural aspects of the ATP-binding domain in inflammasome-forming human NLRP proteinsATP binding by NLRP7 is required for inflammasome activation in response to bacterial lipopeptidesNLRP3 inflammasome: from a danger signal sensor to a regulatory node of oxidative stress and inflammatory diseases.The clinical continuum of cryopyrinopathies: novel CIAS1 mutations in North American patients and a new cryopyrin modelAnalysis of the genetic basis of periodic fever with aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome.Cryopyrin/NALP3 binds ATP/dATP, is an ATPase, and requires ATP binding to mediate inflammatory signaling.Pathogen sensing by nucleotide-binding oligomerization domain-containing protein 2 (NOD2) is mediated by direct binding to muramyl dipeptide and ATP.Peptidoglycan signaling in innate immunity and inflammatory disease.Genetics of Crohn disease, an archetypal inflammatory barrier disease.NOD1 and NOD2 Signaling in Infection and Inflammation.Structural Mechanisms in NLR Inflammasome Assembly and Signaling.In vitro analysis of the functional effects of an NLRP3 G809S variant with the co-existence of MEFV haplotype variants in atypical autoinflammatory syndrome.Mutations in the NB-ARC domain of I-2 that impair ATP hydrolysis cause autoactivation.A new CARD15 mutation in Blau syndrome.Genetische Ätiologie bei chronisch-entzündlichen Darmerkrankungen
P2860
Q24301721-A5D86488-463E-43C6-8F11-4AF30B7EEA89Q24316380-72BB10E2-192C-4BF5-9BE4-05D84CFB6ED7Q26852840-1B6C6787-E1EB-4B53-AA1F-DDDAE33556B7Q28388318-AF6FE3C3-B1FE-47F7-99CD-46E83A1E69FCQ35045146-8D54DC1A-EF2A-4A78-B268-A64A48DBDD51Q35064730-041723B5-B677-4BCF-AEAD-7D9E3611F81CQ35623377-36634DBA-6314-4AD4-8F0C-BA0548AE1541Q35808888-D7FFD443-C624-4206-8EE9-FDA76FA56169Q36080388-2C125C6A-701E-46EF-A725-63FCC5103280Q36085297-75F754FB-9D92-4A8A-9018-E4B3B8979CFEQ36110574-B36A82C1-D63A-4D0A-A5B8-BB96C881AE65Q38060719-FE5B2178-4BA0-48F3-9F3B-4263E3962F04Q38909260-62A1DA02-4B63-42CB-957B-631A7C8946BCQ39270778-A5846A23-D125-4568-9459-BF3161157A7CQ42680832-0D2E6D1B-781C-4EC7-B7EA-F88BE4D6A27FQ46423961-0C6556B7-A843-44E3-9635-F5F325CFEE4BQ57244508-1804232F-C443-4794-B7AB-C8E6117CBEF2
P2860
Structural localization of disease-associated sequence variations in the NACHT and LRR domains of PYPAF1 and NOD2.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Structural localization of dis ...... RR domains of PYPAF1 and NOD2.
@en
Structural localization of dis ...... RR domains of PYPAF1 and NOD2.
@nl
type
label
Structural localization of dis ...... RR domains of PYPAF1 and NOD2.
@en
Structural localization of dis ...... RR domains of PYPAF1 and NOD2.
@nl
prefLabel
Structural localization of dis ...... RR domains of PYPAF1 and NOD2.
@en
Structural localization of dis ...... RR domains of PYPAF1 and NOD2.
@nl
P2860
P1433
P1476
Structural localization of dis ...... LRR domains of PYPAF1 and NOD2
@en
P2093
Mario Albrecht
Stefan Schreiber
P2860
P304
P356
10.1016/S0014-5793(03)01222-5
P407
P577
2003-11-01T00:00:00Z